229 related articles for article (PubMed ID: 14999938)
1. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
[TBL] [Abstract][Full Text] [Related]
3. [A case of chronic myeloid leukemia following TS-1 therapy for advanced gastric cancer].
Higuchi M; Nishinaka H; Yamano Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2049-52. PubMed ID: 17197751
[TBL] [Abstract][Full Text] [Related]
4. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
[TBL] [Abstract][Full Text] [Related]
5. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group].
Chybicka A; Bogusławska-Jaworska J; Kałwak K; Turkiewicz D; Armata J; Balcerska A; Cwiklińska M; Hicke-Roberts A; Kaczmarek-Kanold M; Kołecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Wiśniewska-Slusarz H; Wysocki M; Wachowiak J
Wiad Lek; 1998; 51 Suppl 4():33-9. PubMed ID: 10731941
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia.
Sawyers CL
N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
[No Abstract] [Full Text] [Related]
7. Alpha-interferon and pregnancy in a patient with CML.
Lipton JH; Derzko CM; Curtis J
Hematol Oncol; 1996 Sep; 14(3):119-22. PubMed ID: 9119356
[TBL] [Abstract][Full Text] [Related]
8. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
[No Abstract] [Full Text] [Related]
9. [Interferon therapy for chronic myelogenous leukemia].
Shibata A; Hashimoto S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
[TBL] [Abstract][Full Text] [Related]
10. [A modern therapeutic strategy in Ph-positive chronic myeloleukemia].
Khoroshko ND; Turkina AG; Zhuravlev VS; Sokolova MA; Mikhaĭlova IN; Zakharova AV; Domracheva EV; Semenova EA
Ter Arkh; 1996; 68(7):22-7. PubMed ID: 8928067
[TBL] [Abstract][Full Text] [Related]
11. [Chronic myelocytic leukemia induced into remission by interferon-alpha associated with early esophageal cancer].
Annoh S; Umeda M; Arai N; Shikoshi K; Su CY; Yasushi T; Kitazawa Y; Shirai T
Rinsho Ketsueki; 1991 Jul; 32(7):786-90. PubMed ID: 1920843
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapy.
Guilhot F; Ahmad M; Mahon FX; Dreyfus B; Brizard A; Huret JL; Kitzis A; Tanzer J
Nouv Rev Fr Hematol (1978); 1990; 32(5):287-8. PubMed ID: 2099398
[TBL] [Abstract][Full Text] [Related]
13. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
[TBL] [Abstract][Full Text] [Related]
14. [Chronic myelogenous leukemia maintained in remission by interferon alpha presenting with bladder cancer].
Kobayashi H; Ogawa T
Rinsho Ketsueki; 1989 Jul; 30(7):1093-4. PubMed ID: 2810796
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
[No Abstract] [Full Text] [Related]
16. [The assessment of therapeutic success in chronic myeloid leukemia].
Griesshammer M; Hehlmann R; Heimpel H
Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
[No Abstract] [Full Text] [Related]
17. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
18. [Imatinib therapy for patients with chronic myelogenous leukemia].
Usui N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812
[TBL] [Abstract][Full Text] [Related]
19. [Interferon-alpha in chronic myeloid leukemia].
Hehlmann R
Fortschr Med; 1997 Mar; 115(9):30-4, 37-8. PubMed ID: 9206694
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon.
Breccia M; Diverio D; Pane F; Nanni M; Russo E; Biondo F; Frustaci A; Gentilini F; Alimena G
Leuk Res; 2006 Dec; 30(12):1577-9. PubMed ID: 16630657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
